Vital Farms stock hits 52-week high at 45.79 USD

Vital Farms Inc. (VITL) stock reached a new 52-week high, hitting 45.79 USD. With a market capitalization of $2 billion and an impressive revenue growth of 24% over the last twelve months, the company has caught investors’ attention. InvestingPro analysis indicates the stock may be entering overbought territory. This milestone reflects a significant upward trend, as the company’s stock has experienced a notable 46.24% increase over the past year. The rise in stock price underscores investor confidence, supported by the company’s solid financial health score of "GREAT" on InvestingPro and strong balance sheet with more cash than debt. The achievement marks a strong period for the company, as it continues to navigate the competitive landscape of the food production industry with a robust current ratio of 3.35, indicating excellent operational efficiency. Discover 15 additional key insights about VITL with an InvestingPro subscription, including detailed valuation metrics and growth projections.

In other recent news, Vital Farms has reported strong second-quarter 2025 earnings, exceeding analyst expectations. The company achieved adjusted earnings per share of $0.36, surpassing both Telsey Advisory Group’s forecast of $0.27 and the FactSet consensus of $0.28. Revenue for the quarter reached $185 million, which was higher than BMO Capital’s estimate of $174 million and the consensus forecast of $171 million. The company also reported a 15% year-over-year volume growth and a sales increase of 25.4% to $184.8 million, beating analyst expectations of $170 million.

Following these results, several firms have raised their price targets for Vital Farms. TD Cowen increased its target to $48 from $42, maintaining a Buy rating, while Morgan Stanley (NYSE:MS) also raised its target to $48 from $41, citing the company’s significant topline growth potential. BMO Capital and Telsey Advisory Group both increased their price targets to $50, highlighting the strong quarterly performance. Management has also raised its 2025 guidance above consensus estimates, further boosting investor confidence.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.